首页> 外文OA文献 >Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

【2h】

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

机译：在Re-Ly（长期抗凝治疗的随机评估）试验中，用Dabigatran或Warfarin治疗心房颤动治疗心房颤动的心肌缺血事件

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Stefan H. Hohnloser; Jonas Oldgren; Sean Yang; Lars Wallentin; Michael Ezekowitz; Paul Reilly; John Eikelboom; Martina Brueckmann; Salim Yusuf; Stuart J. Connolly;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized evaluation of long-term anticoagulation therapy) trial [J] . HohnloserS.H., OldgrenJ., YangS., Circulation: An Official Journal of the American Heart Association . 2012,第5期

机译：在RE-LY（长期抗凝治疗的随机评估）试验中，使用达比加群或华法林治疗的房颤患者的心肌缺血事件
2. Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial [J] . Alak Aiman, Hohnloser Stefan H., Fraessdorf Mandy, Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . 2019,第7期

机译：在长期抗凝治疗（RE-LY）试验中，用Dabigatran或Warfarin治疗心房颤动治疗心房颤动患者的住院原因和死亡率风险
3. Response to Letter Regarding Article, "Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis" [J] . Hijazi Ziad, Hohnloser Stefan H., Oldgren Jonas, Circulation: An Official Journal of the American Heart Association . 2014,第22期

机译：对有关“达比加群与华法林相比房颤患者基线肾功能的有效性和安全性的信”的答复：RE-LY（长期抗凝治疗的随机评估）试验分析”
4. Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients [C] . Shijing Guo, Xiang Li, Xin Du, MEDINFO . 2017

机译：基于组的术语轨迹分析，用于高级患者的华法林治疗
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial [O] . Samuel W. Reinhardt, Nihar R. Desai, Yuanyuan Tang, 2021

机译：个性化Dabigatran与华法林在心房颤动的决定：长期抗凝治疗的随机评价（RE-LY）试验的二级分析
7. The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy) [O] . Reilly Paul A., Lehr Thorsten, Haertter Sebastian, 2014

机译：达比加群血浆浓度和患者特征对房颤患者缺血性卒中和大出血频率的影响RE-LY试验（长期抗凝治疗的随机评估）

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

著录项

引文网络

相似文献

相关主题

期刊订阅